Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer

被引:22
|
作者
Kappers, Ingrid [1 ]
Klomp, Houke M. [1 ]
Burgers, Jacobus A. [2 ]
Van Zandwijk, Nico [2 ]
Haas, Rick L. M. [3 ]
van Pel, Renee [4 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
关键词
D O I
10.1200/JCO.2008.16.3709
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:4205 / 4207
页数:3
相关论文
共 50 条
  • [31] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
  • [32] Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer
    Pérez-Soler, R
    Chachoua, A
    Hammond, LA
    Rowinsky, EK
    Huberman, M
    Karp, D
    Rigas, J
    Clark, GM
    Santabàrbara, P
    Bonomi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3238 - 3247
  • [33] IMPACT OF NEOADJUVANT RADIATION ON SURVIVAL IN STAGE III NON-SMALL-CELL LUNG CANCER
    Koshy, Matthew
    Goloubeva, Olga
    Suntharalingam, Mohan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1388 - 1394
  • [34] Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer
    Betticher, DC
    Rosell, R
    LUNG CANCER, 2004, 46 : S23 - S32
  • [35] Outcome of combined-modality treatment for stage IIIA non-small-cell lung cancer
    ElSayed, S
    Paprocki, I
    Mihalciou, C
    Chowdhury, A
    Leylek, A
    Unruh, H
    RADIOLOGY, 1996, 201 : 1498 - 1498
  • [36] Is surgery indicated for stage IIIA-N2 non-small-cell lung cancer?
    Gounant, V.
    Lavole, A.
    Epaud, C.
    Rosencher, L.
    Milleron, B.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2007, 63 (03) : 135 - 137
  • [37] Treatment of Stage IIIA Non-Small-Cell Lung Cancer: A Concise Review for the Practicing Oncologist
    Santana-Davila, Rafael
    Martins, Renato
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (07) : 601 - +
  • [38] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer
    Movsas, B
    ONCOLOGY-NEW YORK, 2002, 16 (01): : 90 - +
  • [39] Combined modality therapy for non-small-cell lung cancer (NSCLC): Stage IIIA disease
    van Zandwijk, N
    LUNG CANCER, 2004, 45 : S19 - S20
  • [40] Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
    Pless, Miklos
    Stupp, Roger
    Ris, Hans-Beat
    Stahel, Rolf A.
    Weder, Walter
    Thierstein, Sandra
    Gerard, Marie-Aline
    Xyrafas, Alexandros
    Frueh, Martin
    Cathomas, Richard
    Zippelius, Alfred
    Roth, Arnaud
    Bijelovic, Milorad
    Ochsenbein, Adrian
    Meier, Urs R.
    Mamot, Christoph
    Rauch, Daniel
    Gautschi, Oliver
    Betticher, Daniel C.
    Mirimanoff, Rene-Olivier
    Peters, Solange
    LANCET, 2015, 386 (9998): : 1049 - 1056